CYRX · Cryoport, Inc.
$15.23
+0.30 (+1.98%)
At close · Jul 30
Market Cap
$752.51M
Shares
50.40M
Cryoport, Inc. Earnings Call Transcripts
Every quarterly earnings call for Cryoport, Inc. (CYRX) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲6.7%
$60.46M
−$5.32M
'22 Q3
22-11-03
·
$60.36M
−$9.44M
'22 Q4
23-02-23
▲20.1%
$62.82M
−$5.57M
'23 Q1
23-05-04
▼11.1%
$57.02M
−$18.36M
'23 Q2
23-08-09
▼7.1%
$56.16M
−$13.27M
'23 Q3
23-11-08
▼5.1%
$57.26M
−$62.39M
'23 Q4
24-03-12
▼13.1%
$54.59M
−$18.89M
'24 Q1
24-05-07
▲1%
$57.60M
−$77.99M
'24 Q2
24-08-06
▲0.9%
$56.66M
$805,000
'24 Q3
24-11-07
▲4%
$59.53M
−$18.68M
'24 Q4
25-03-04
▼24.8%
$41.04M
−$11.98M
'25 Q1
25-05-07
▼21.1%
$45.45M
$105.18M
'25 Q2
25-08-06
▼21.9%
$44.23M
−$6.94M
'25 Q3
25-11-04
▼23.7%
$45.45M
−$7.96M
'25 Q4
26-03-03
LATEST
▲16.5%
$47.80M
−$10.54M
'26 Q1
26-05-04
Earnings call
FY26 · Q2
2026-08-06
Second Quarter 2026 Results Q&A Call
Scheduled
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Annual General Meeting
Investor event
2026-06-05
2026 Annual Meeting of Stockholders
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-04
Cryoport, Inc. Q1 FY2026 Earnings Call
Confident tone
Cell and gene therapy commercial pipeline
Revenue growth and segment performance
IntegraCell cell therapy manufacturing
Revenue
$47.80M
▲ 16.5% YoY Diluted EPS
$-0.25
Gross margin
45.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-03
Cryoport, Inc. Q4 FY2025 Earnings Call
Positive tone
MVE Biological Solutions and cryogenic products
Commercial cell and gene therapy revenue growth
Financial performance and guidance
Revenue
$45.45M*
▼ 23.7% YoY Gross margin
47.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-04
Cryoport, Inc. Q3 FY2025 Earnings Call
Confident tone
Life Sciences Products / MVE cryogenic systems
Cell and gene therapy commercial support growth
Life Sciences Services segment performance
Revenue
$44.23M
▼ 21.9% YoY Diluted EPS
$-0.18
Gross margin
48.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
Cryoport, Inc. Q2 FY2025 Earnings Call
Confident tone
MVE Products and Animal Health Demand
Pathway to Profitability and Margin Expansion
FDA/Regulatory Headwinds and Client Setbacks
Revenue
$45.45M
▼ 21.1% YoY Diluted EPS
$2.05
Gross margin
47.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Cryoport, Inc. Q1 FY2025 Earnings Call
Confident tone
DHL Strategic Partnership
Tariffs and Supply Chain
Cell and Gene Therapy Commercial Growth
Revenue
$41.04M
▼ 24.8% YoY Diluted EPS
$-0.28
Gross margin
45.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-04
Cryoport, Inc. Q4 FY2024 Earnings Call
Positive tone
Cost management and gross margin improvement
MVE / Life Sciences Products stabilization
IntegriCell cryopreservation launch
Revenue
$59.53M*
▲ 4% YoY Gross margin
45.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Cryoport, Inc. Q3 FY2024 Earnings Call
Positive tone
Life Sciences Services growth
Cost reduction and profitability
IntegriCell and CRYOGENE expansion
Revenue
$56.66M
▲ 0.9% YoY Diluted EPS
$-0.02
Gross margin
44.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Cryoport, Inc. Q2 FY2024 Earnings Call
Positive tone
Path to Profitability and Adjusted EBITDA
China Market Challenges
Cell and Gene Therapy Commercial Ramp
Revenue
$57.60M
▲ 1% YoY Diluted EPS
$-1.62
Gross margin
43.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Cryoport, Inc. Q1 FY2024 Earnings Call
Cautious tone
MVE Cryogenic Systems Weakness
BioStorage/BioServices Growth
Cell and Gene Therapy Momentum
Revenue
$54.59M
▼ 13.1% YoY Diluted EPS
$-0.43
Gross margin
39.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-12
Cryoport, Inc. Q4 FY2023 Earnings Call
Positive tone
MVE Biological Solutions
2024 Guidance and Conservative Outlook
CRYOPDP U.S. Expansion
Revenue
$57.26M*
▼ 5.1% YoY Gross margin
40.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-08
Cryoport, Inc. Q3 FY2023 Earnings Call
Revenue
$56.16M
▼ 7.1% YoY Diluted EPS
$-0.31
Gross margin
43.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
Cryoport, Inc. Q2 FY2023 Earnings Call
Revenue
$57.02M
▼ 11.1% YoY Diluted EPS
$-0.42
Gross margin
43.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
Cryoport, Inc. Q1 FY2023 Earnings Call
Revenue
$62.82M
▲ 20.1% YoY Diluted EPS
$-0.16
Gross margin
43.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-23
Cryoport, Inc. Q4 FY2022 Earnings Call
Revenue
$60.36M
Diluted EPS
$-0.24
Gross margin
43.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Cryoport, Inc. Q3 FY2022 Earnings Call
Revenue
$60.46M
▲ 6.7% YoY Diluted EPS
$-0.15
Gross margin
43.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Cryoport, Inc. Q2 FY2022 Earnings Call
Revenue
$64.15M
▲ 14.2% YoY Diluted EPS
$-0.23
Gross margin
45.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Cryoport, Inc. Q1 FY2022 Earnings Call
Revenue
$52.30M
▼ 1.8% YoY Diluted EPS
$-0.31
Gross margin
42.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Cryoport, Inc. Q4 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Cryoport, Inc. Q3 FY2021 Earnings Call
Revenue
$56.69M
▲ 407.5% YoY Diluted EPS
$-0.17
Gross margin
41.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Cryoport, Inc. Q2 FY2021 Earnings Call
Revenue
$56.19M
▲ 498.5% YoY Gross margin
45.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Cryoport, Inc. Q1 FY2021 Earnings Call
Revenue
$53.28M
▲ 445.2% YoY Gross margin
46.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-01-20
Cryoport, Inc. Q4 FY2020 Earnings Call
Revenue
$56.44M
▲ 510.7% YoY Diluted EPS
$-5.46
Gross margin
41.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Cryoport, Inc. Q3 FY2020 Earnings Call
Revenue
$11.17M
▲ 16.6% YoY Gross margin
54.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-07
Cryoport, Inc. Q2 FY2020 Earnings Call
Revenue
$9.39M
▲ 10.9% YoY Gross margin
54.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Cryoport, Inc. Q1 FY2020 Earnings Call
Revenue
$9.77M
▲ 46.9% YoY Gross margin
53.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-05
Cryoport, Inc. Q4 FY2019 Earnings Call
Revenue
$9.24M
▲ 62.4% YoY Gross margin
53.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–28 of 28 earnings calls
Key facts
CIK
1124524
CUSIP
229050307
13F (30d)
29 filings
29 filers
Visit website
Investor relations